首页> 美国卫生研究院文献>Frontiers in Psychiatry >Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis
【2h】

Treatment-Resistant to Antipsychotics: A Resistance to Everything? Psychotherapy in Treatment-Resistant Schizophrenia and Nonaffective Psychosis: A 25-Year Systematic Review and Exploratory Meta-Analysis

机译:抗精神病药抗药性:对一切都有抵抗力吗?抗治疗型精神分裂症和非情感性精神病的心理治疗:25年系统评价和探索性荟萃分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

>Background: Roughly 30% of schizophrenia patients fail to respond to at least two antipsychotic trials. Psychosis has been traditionally considered to be poorly sensitive to psychotherapy. Nevertheless, there is increasing evidence that psychological interventions could be considered in treatment-resistant psychosis (TRP). Despite the relevance of the issue and the emerging neurobiological underpinnings, no systematic reviews have been published. Here, we show a systematic review of psychotherapy interventions in TRP patients of the last 25 years. >Methods: The MEDLINE/PubMed, ISI WEB of Knowledge, and Scopus databases were inquired from January 1, 1993, to August 1, 2018, for reports documenting augmentation or substitution with psychotherapy for treatment-resistant schizophrenia (TRS) and TRP patients. Quantitative data fetched by Randomized Controlled Trials (RCTs) were pooled for explorative meta-analysis. >Results: Forty-two articles have been found. Cognitive behavioral therapy (CBT) was the most frequently recommended psychotherapy intervention for TRS (studies, n = 32, 76.2%), showing efficacy for general psychopathology and positive symptoms as documented by most of the studies, but with uncertain efficacy on negative symptoms. Other interventions showed similar results. The usefulness of group therapy was supported by the obtained evidence. Few studies focused on negative symptoms. Promising results were also reported for resistant early psychosis. >Limitations: Measurement and publication bias due to the intrinsic limitations of the appraised original studies. >Conclusions: CBT, psychosocial intervention, supportive counseling, psychodynamic psychotherapy, and other psychological interventions can be recommended for clinical practice. More studies are needed, especially for non-CBT interventions and for all psychotherapies on negative symptoms.
机译:>背景:大约30%的精神分裂症患者对至少两项抗精神病药物试验没有反应。传统上认为精神病对心理治疗的敏感性较差。然而,越来越多的证据表明可以在抗药性精神病(TRP)中考虑心理干预。尽管该问题的相关性和新兴的神经生物学基础,但尚未发表系统的综述。在这里,我们显示了过去25年中对TRP患者进行心理治疗干预的系统评价。 >方法:从1993年1月1日至2018年8月1日,查询MEDLINE / PubMed,ISI WEB知识数据库和Scopus数据库,以获取报告证明用心理疗法增强或替代耐药性精神分裂症( TRS)和TRP患者。汇总通过随机对照试验(RCT)获取的定量数据,进行探索性荟萃分析。 >结果:找到四十二篇文章。认知行为疗法(CBT)是TRS的最常推荐的心理治疗干预措施(研究,n = 32,76.2%),显示出对一般精神病理学和阳性症状的疗效,正如大多数研究所证明的那样,但对阴性症状的疗效尚不确定。其他干预措施也显示了相似的结果。获得的证据支持了团体疗法的有用性。很少有研究关注负面症状。抗药性早期精神病也有希望的结果。 >局限性:由于所评估的原始研究的固有局限性,导致衡量和出版偏见。 >结论:CBT,心理社会干预,支持咨询,心理动力心理治疗以及其他心理干预措施可建议用于临床实践。需要进行更多的研究,特别是对于非CBT干预和所有对阴性症状进行的心理治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号